Healthcare / Health Information ServicesTokyo
$503.00
+3.00 (+0.60%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $914.2M · quality 82.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
64/100
B
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$23.9B
P/E
18.9x
↓EV/EBITDA
10.4x
↓ROE
23.9%
↑Gross Margin
64.3%
↑Debt/Equity
0.14
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+30.0%
FCF CAGR
+24.0%
FCF margin
16.6%
FCF / Net income
0.82x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $5.50B · net income $1.11B · FCF $914.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $5.50B | $5.50B | $5.01B | $3.75B | $2.50B |
| Net Income | $1.11B | $1.11B | $920.0M | $763.1M | $685.5M |
| EBITDA | $2.04B | $2.04B | $1.71B | $1.40B | $1.16B |
| EPS | 23.42 | 23.42 | 19.38 | 15.58 | 13.74 |
| Gross Margin | 64.3% | 64.3% | 61.4% | 69.2% | 83.9% |
| Operating Margin | 29.2% | 29.2% | 28.7% | 29.3% | 38.5% |
| Net Margin | 20.2% | 20.2% | 18.4% | 20.4% | 27.4% |
| Balance Sheet | |||||
| Debt/Equity | 0.14 | 0.14 | 0.24 | 0.40 | 1.26 |
| Current Ratio | 5.76 | 5.76 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $914.2M | $914.2M | $1.15B | $789.1M | $478.9M |
| Returns | |||||
| ROE | 23.9% | 23.9% | 24.0% | 24.0% | 26.9% |
| Valuation | |||||
| P/E | 18.90 | 18.90 | 27.19 | 32.03 | 43.60 |
| EV/EBITDA | 10.41 | 10.41 | 13.13 | 16.35 | 24.58 |
| P/B | 5.13 | 5.13 | 6.52 | 7.70 | 11.72 |
| Growth & Yield | |||||
| Revenue Growth | 9.9% | 9.9% | 33.7% | 49.7% | — |
| EPS Growth | 20.8% | 20.8% | 24.4% | 13.4% | — |
| Dividend Yield | 1.8% | 1.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
24.0%
EPS terminal req.
$44.63
Spread vs growth
-3.1%
5Y implied EPS CAGR
18.2%
EPS terminal req.
$54.01
Spread vs growth
2.7%
10Y implied EPS CAGR
14.0%
EPS terminal req.
$86.98
Spread vs growth
6.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+23.9%
Start / end P/E
21.3x → 21.5x
EPS bridge
19.38 → 23.42
Residual
+0.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.